Authors:
JOHNSON LN
KROHEL GB
LEE AG
MADSEN RW
ORENGONANIA S
YEE RD
Citation: Ln. Johnson et al., DURATION OF VISUAL IMPROVEMENT FOLLOWING LEVODOPA AND CARBIDOPA USE IN NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION), Investigative ophthalmology & visual science, 38(4), 1997, pp. 4494-4494
Citation: Ln. Johnson et al., EFFECT OF LEVODOPA AND CARBIDOPA ON RECOVERY OF VISUAL FUNCTION IN PATIENTS WITH NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY OF LONGER THAN 6 MONTHS DURATION, American journal of ophthalmology, 121(1), 1996, pp. 77-83
Citation: Tj. Gould et al., LEVODOPA CARBIDOPA IMPROVES VISUAL FUNCTION IN PATIENTS WITH NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION) OF GREATER-THAN 6 MONTHS DURATION, Investigative ophthalmology & visual science, 36(4), 1995, pp. 196-196
Citation: Ln. Johnson et al., RECURRENT HERPES LABIALIS IS A POTENTIAL RISK FACTOR FOR NONARTERITICANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION), Investigative ophthalmology & visual science, 35(4), 1994, pp. 1542-1542